SUSAN EVANS: Open Payments
NPI 1376143446 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,745 in 94 payments from 23 companies in 2025. Trend: 2023 $2,310 · 2024 $1,872 · 2025 $1,745
Food & beverage: $1,745
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $248 |
| ABBVIE INC. | 10 | $200 |
| Novo Nordisk Inc | 7 | $159 |
| AstraZeneca Pharmaceuticals LP | 5 | $135 |
| Lilly USA, LLC | 9 | $133 |
| Insulet Corporation | 4 | $114 |
| PFIZER INC. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Antares Pharma, Inc. | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
Products named: OTEZLA, REXULTI, Omnipod, NURTEC ODT, FARXIGA, JARDIANCE, XYOSTED, Ozempic.
Industry payments across GA — which companies pay providers there.
